Trimethoprim-d3 (CAS 1189923-38-3)

Trimethoprim-d3, a deuterium-labeled derivative of trimethoprim, has garnered significant interest in scientific research, particularly in pharmacokinetic and pharmacodynamic studies. Deuterium labeling involves the substitution of hydrogen atoms with deuterium, a stable isotope of hydrogen, altering the mass of the molecule while preserving its chemical properties. This modification allows for precise tracking and quantification of the compound′s distribution, metabolism, and elimination within biological systems using advanced analytical techniques such as mass spectrometry. Trimethoprim-d3 serves as a valuable tool in elucidating the pharmacokinetic parameters and bioavailability of trimethoprim, an antimicrobial agent widely used to treat bacterial infections. Researchers leverage Trimethoprim-d3 to investigate drug absorption, distribution, metabolism, and excretion (ADME) properties in both preclinical and clinical settings, providing crucial insights into its behavior and efficacy in vivo. Additionally, Trimethoprim-d3 serves as a reference standard for developing and validating analytical methods to quantify trimethoprim levels in biological samples, enhancing the accuracy and reliability of pharmacokinetic assessments. Its widespread utilization underscores its significance in advancing our understanding of antimicrobial pharmacology and optimizing strategies against bacterial pathogens through rigorous scientific research.